GL1X · GenesisL1 explorer

MolNFT v1 · #37411 · protein

Structure-based drug design of a novel family of ppar partial agonists: virtual screening, X-ray crystallography and in VITRO/IN vivo biological activities

2G0H · Peroxisome proliferator-activated receptor gamma: “Structure-based drug design of a novel family of ppar partial agonists: virtual screening, X-ray…”. X-ray diffraction, 1 ligand (SP3), 5 pockets (best druggability 0.85). MolNFT v1…

PDB
2G0H
Type
protein
Length
542 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma
UniProt
Q86U60
Ligands
SP3
Pockets
5 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 62% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPeroxisome proliferator-activated receptor gammaprotein27162% helix, 2% strandQ86U60

Ligands and binding sites

  • SP3 · N-[1-(4-fluorophenyl)-3-(2-thienyl)-1H-pyrazol-5-yl]-3,5-bis(trifluoromethyl)benzenesulfonamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17870.850.8881SP3
27130.840.8775SP3
36820.770.8268empty
41460.420.7524empty
5650.290.7414empty

Interfaces

1 interface between chains.

  • A–B · 793 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 2G0H · Structure-based drug design of a novel family of PPAR partial agonists: virtual… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.